Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neuralgia × KRN 5500 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neuralgia 1 Neoplasms 1

Interventions

Pregabalin 3 ziconotide 1 Thalidomide 1 Telmisartan 1 Oxycodone 1 KRN 5500 1 Gabapentin 1 Cholecalciferol 1 Capsaicin 1 Bupivacaine 1 Amitriptyline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00474916 2010-08-16

Neuropathic Pain in Patients With Cancer

DARA Therapeutics

Phase 2 Completed

Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡